deucravacitinib,apremilast
bms,amgen
['psoriasis', 'deucrava', 'deucra', '$bmy', 'bristol']
bristol myers squibb - u.s. food and drug administration approves sotyktu (deucravacitinib), oral treatment for adults with moderate-to-severe plaque psoriasis $bmy 
No investment advice. Do your own DD Market is all about taking the shares from the weak holders& providing opportunities to those that have the stamina to hold